The Meningitis Vaccine Project (MVP) released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine?expected to sell initially for 40 US cents a dose?will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.
The United Nations Children’s Fund (UNICEF) and its partners are working to vaccinate 2 million children against polio in Zimbabwe, where most families are suffering from deteriorating economic conditions.
The Meningitis Vaccine Project today released new data on the performance of a meningitis vaccine in West African children, suggesting that the new vaccine — expected to sell initially for 40 US cents a dose — will be much more effective in protecting African children and their communities than any vaccine currently on the market in the region.
Speaking at the meeting of Indian Health Ministers of polio affected States organized to review the status of polio eradication efforts, the Indian Minister for Health & Family Welfare, Dr. Anbumani Ramadoss said that it is critical to sustain the high level of immunity in all polio-affected States by vaccinating all children under the age of five both through routine immunization and Supplementary Immunization Activities (SIAs), so that the polio virus does not get a chance to re-establish its circulation.
US HHS Secretary Mike Leavitt announced that HHS has awarded a contract for $500 million to Bavarian Nordic A/S of Copenhagen, Denmark to manufacture and deliver 20 million doses of a next generation modified vaccinia Ankara (MVA) smallpox vaccine.
A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus (HPV) responsible for most cases of cervical cancer?strains 16 and 18.
New research conducted at the Uniformed Services University of the Health Sciences (USU) suggests that it may be possible to develop a vaccine that protects against the myriad strains of the HIV virus.
Girls in King County and across Washington state will now have access to a new vaccine at no cost that prevents cancer caused by the human papillomavirus (HPV).
Iomai Corporation (Nasdaq: IOMI) announced interim results from a Phase 1 clinical trial of its patch-based vaccine for seasonal influenza.
Today, the Director of Health and the Health Insurance Commissioner jointly released the eighth annual publication of the Rhode Island Health Plans? Performance Report . This Report, based on 2005 submissions to the National Committee for Quality Assurance (NCQA), provides information on 29 separate measures covering 7 dimensions of performance (i.e., enrollment, utilization, prevention, screening, treatment, access, and satisfaction). Health plan performance is both trended over time and compared to regional and national averages.